2012The Chinese Journal of Clinical PharmacologyRequires access

Bioequivalence of letrozole tablet in Chinese healthy volunteers

Pengfei Li

Open publisher page 0 citations

Abstract

Objective To evaluate the pharmacokinetics and relative bioavailability of letrozole tablet in healthy volunteers.Methods A single oral doses of 2.5 mg letrozole tablet(reference and test) were given to 24 healthy volunteers according to an open randomized crossover design.The concentrations of reference and test tablets in plasma were determined by LC-MS/MS.Results The pharmacokinetic parameters of test drug and reference drug were as follows: Cmax were(24.48±5.72),(26.17±5.55) ng·mL-1,Tmax were(1.88±1.04),(1.98±1.26) h,t1/2 were(60.04±34.45),(55.31±23.05) h,AUC0-t were(1749.08±859.64),(1793.65±808.62) ng·h·mL-1,AUC0-∞ were(1949.90±1254.63),(1918.28±955.15) ng·h·mL-1,respectively.The relative bioavailability was(97.94±13.35)%.Conclusion The test preparation was bioequivalent to the referent preparation.

About this research paper

What this paper is about

Objective To evaluate the pharmacokinetics and relative bioavailability of letrozole tablet in healthy volunteers.Methods A single oral doses of 2.5 mg letrozole tablet(reference and test) were given to 24 healthy volunteers according to an open randomized crossover design.The concentrations of reference and test tablets in plasma were determined by LC-MS/MS.Results The pharmacokinetic parameters of test drug and reference drug were as follows: Cmax were(24.48±5.72),(26.17±5.55) ng·mL-1,Tmax were(1.88±1.04),(1.98±1.26) h,t1/2 were(60.04±34.45),(55.31±23.05) h,AUC0-t were(1749.08±859.64),(1793.65±808.62) ng·h·mL-1,AUC0-∞ were(1949.90±1254.63),(1918.28±955.15) ng·h·mL-1,respectively.The relative bioavailability was(97.94±13.35)%.Conclusion The test preparation was bioequivalent to the referent preparation.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the pharmacokinetics and relative bioavailability of letrozole tablet in healthy volunteers.Methods A single oral doses of 2.5 mg letrozole tablet(reference and test) were given to 24 healthy volunteers according to an open randomized crossover design.The concentrations of reference and test tablets in plasma were determined by LC-MS/MS.Results The pharmacokinetic parameters of test drug and reference drug were as follows: Cmax were(24.48±5.72),(26.17±5.55) ng·mL-1,Tmax were(1.88±1.04),(1.98±1.26) h,t1/2 were(60.04±34.45),(55.31±23.05) h,AUC0-t were(1749.08±859.64),(1793.65±808.62) ng·h·mL-1,AUC0-∞ were(1949.90±1254.63),(1918.28±955.15) ng·h·mL-1,respectively.The relative bioavailability was(97.94±13.35)%.Conclusion The test preparation was bioequivalent to the referent preparation.

Key concepts: Bioequivalence, Bioavailability, Cmax, Letrozole, Pharmacokinetics, Crossover study, Pharmacology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of letrozole tablet in Chinese healthy volunteers — Research Paper | ScholarLens